Correction {#Sec1}
==========

After the publication of this work \[[@CR1]\] errors were noticed in the total protein loading controls for Figs. [1C](#Fig1){ref-type="fig"}, [2B](#Fig2){ref-type="fig"}, [3B](#Fig3){ref-type="fig"} and [4B](#Fig4){ref-type="fig"}. These errors do not affect the interpretation of the data. The corrected figures are shown below. We apologize for this error.Fig. 1Effect of 17β-oestradiol and EGF on cell proliferation and induction of MAPK protein expression in breast cancer cells. **(c)** SKBR3 breast cancer cells were treated with 5, 10 and 50 ng/ml EGF and 17β-oestradiol (10^− 8^ mol/l) alone and in combination for 10 min. 40 μg protein was electrophoresed on a 10% gel and transferred to nitrocellulose. The membrane was probed with rabbit anti-Phospho-Erk1/2 antibody (Thr202/Tyr204 - Cell Signalling \# 4370) and mouse anti-Erk1/2 antibody (Cell Signalling \# 4696)Fig. 217β-oestradiol and EGF induced cell proliferation and raf phosporylation is mediated through EGFR. **(b)** SKBR3 and MCF-7 breast cancer cells were pre-treated with the EGFR antagonist AG1478 (150 nmol/l) for 1 h before 10 min of incubation with EGF (10 ng/ml) and 17β-oestradiol (10^− 8^ mol/l) alone and in combination. 40 μg protein was electrophoresed on a 10% gel and transferred to nitrocellulose. The membrane was probed with rabbit anti-Phospho-Raf antibody (Ser259 - Cell Signalling \# 9421) and mouse anti-Raf antibody (Santa Cruz sc-373,722)Fig. 3Effect of GPCR antagonism on 17β-oestradiol and EGF induced cell proliferation, raf phosporylation and cAMP production in breast cancer cells. **(b)** SKBR3 and MCF-7 cells were pre-treated with the GPCR antagonist pertussis toxin (50 ng/ml) for 1 h before 10 min of incubation with EGF (10 ng/ml) and 17β-oestradiol (10^− 8^ mol/l) alone and in combination. 40 μg protein was electrophoresed on a 10% gel and transferred to nitrocellulose. The membrane was probed with rabbit anti-Phospho-Raf antibody (Ser259 - Cell Signalling \# 9421) and mouse anti-Raf antibody (Santa Cruz sc-373,722)Fig. 4*The role of the AT1 receptor in* 17β-oestradiol and EGF mediated cell proliferation and raf phosphorylation breast cancer cells. **(b)** SKBR3 cells were pre-treated with the AT1 antagonist saralasin (10^− 6^ mol/l) for 1 h before 10 min of incubation with EGF (10 ng/ml) and 17β-oestradiol (10^− 8^ mol/l) alone and in combination. 40 μg protein was electrophoresed on a 10% gel and transferred to nitrocellulose. The membrane was probed with rabbit anti-Phospho-Raf antibody (Ser259 - Cell Signalling \# 9421) and mouse anti-Raf antibody (Santa Cruz sc-373,722)
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